Skip to main content

Central Hypersomnias in Adult Women of Childbearing Age

  • Chapter
  • First Online:
  • 676 Accesses

Part of the book series: Current Clinical Neurology ((CCNEU))

Abstract

The differential diagnosis of primary hypersomnias in women includes narcolepsy (type 1/with cataplexy and type 2/without cataplexy), idiopathic hypersomnia, recurrent hypersomnia (Klein-Levin Syndrome, menstrual-related hypersomnia), idiopathic hypersomnia, behaviorally induced insufficient sleep syndrome, hypersomnia due to a medical disorder, hypersomnia due to a medication or substance, and hypersomnia associated with a psychiatric disorder. The hallmark symptom of hypersomnia is excessive daytime sleepiness (EDS). There is evidence suggesting higher prevalence of EDS in women, possibly due to work and family responsibilities, increased prevalence of mood disorders, hormonal changes, and/or the underdiagnoses of sleep disorders in women. In the realm of recurrent hypersomnias, menstrual-related hypersomnia is especially of importance in the evaluation of women. Similarly, given the increased prevalence of depression in women, the relationship between hypersomnia and depression is important to be aware of in evaluating these patients as well. There are several different options for treatment of primary hypersomnias. Special consideration should be given when prescribing modafinil or armodafinil to women given the interaction of these medications with exogenous hormones and oral contraceptives, leading to reduced efficacy and increased clearance of these hormonal treatments. Not enough pregnancy safety data exists with any of the pharmacological treatments for hypersomnia.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Dauvilliers Y, Barateau L. Narcolepsy and other central hypersomnias. Continuum (Minneap Minn). 2017;23(4):989–1004.

    Google Scholar 

  2. Chasens ER, Twerski SR, Yang K, Umlauf MG. Sleepiness and health in midlife women: results of the National Sleep Foundation’s 2007 sleep in America poll. Behav Sleep Med. 2010;8(3):157–71.

    Article  PubMed  Google Scholar 

  3. Liu X, Uchiyama M, Kim K, et al. Sleep loss and daytime sleepiness in the general adult population of Japan. Psychiatry Res. 2000;93(1):1–11.

    Article  CAS  PubMed  Google Scholar 

  4. Doi Y, Minowa M. Gender differences in excessive daytime sleepiness among Japanese workers. Soc Sci Med. 2003;56(4):883–94.

    Article  PubMed  Google Scholar 

  5. Theorell-Haglow J, Lindberg E, Janson C. What are the important risk factors for daytime sleepiness and fatigue in women? Sleep. 2006;29(6):751–7.

    Article  PubMed  Google Scholar 

  6. Lichstein KL, Durrence HH, Riedel BW, Taylor DJ, Bush AJ. Epidemiology of sleep. (3 should actually be 7). Mahwah: Lawrence Erlbaum Associates; 2004.

    Google Scholar 

  7. Pagel JF. Excessive daytime sleepiness. Am Fam Physician. 2009;79(5):391–6.

    CAS  PubMed  Google Scholar 

  8. Baldwin CM, Kapur VK, Holberg CJ, Rosen C, Nieto FJ. Associations between gender and measures of daytime somnolence in the Sleep Heart Health Study. Sleep. 2004;27(2):305–11.

    Article  PubMed  Google Scholar 

  9. Beaudreau SA, Spira AP, Stewart A, et al. Validation of the Pittsburgh sleep quality index and the Epworth sleepiness scale in older black and white women. Sleep Med. 2011;13(1):36–42.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Liu X, Sun Z, Uchiyama M, Shibui K, Kim K, Okawa M. Prevalence and correlates of sleep problems in Chinese schoolchildren. Sleep. 2000;23(8):1053–62.

    Article  CAS  PubMed  Google Scholar 

  11. Lamarche LJ, Driver HS, Wiebe S, Crawford L, DE Koninck JM. Nocturnal sleep, daytime sleepiness, and napping among women with significant emotional/behavioral premenstrual symptoms. J Sleep Res. 2007;16(3):262–8.

    Article  PubMed  Google Scholar 

  12. Baker FC, Colrain IM. Daytime sleepiness, psychomotor performance, waking EEG spectra and evoked potentials in women with severe premenstrual syndrome. J Sleep Res. 2010;19(1 Pt 2):214–27.

    Article  PubMed  Google Scholar 

  13. Doghramji K, Mitler MM, Sangal RB, et al. A normative study of the maintenance of wakefulness test (MWT). Electroencephalogr Clin Neurophysiol. 1997;103(5):554–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Mitler MM, Doghramji K, Shapiro C. The maintenance of wakefulness test: normative data by age. J Psychosom Res. 2000;49(5):363–5.

    Article  CAS  PubMed  Google Scholar 

  15. American Academy of Sleep Medicine. The international classification of sleep disorders: diagnostic and coding manual. 2nd ed. Westchester: American Academy of Sleep Medicine; 2005.

    Google Scholar 

  16. Rye DB, Dihenia B, Weissman JD, Epstein CM, Bliwise DL. Presentation of narcolepsy after 40. Neurology. 1998;50(2):459–65.

    Article  CAS  PubMed  Google Scholar 

  17. Wise MS. Childhood narcolepsy. Neurology. 1998;50(2 Suppl 1):S37–42.

    Article  CAS  PubMed  Google Scholar 

  18. Black JE, Brooks SN, Nishino S. Narcolepsy and syndromes of primary excessive daytime somnolence. Semin Neurol. 2004;24(3):271–82.

    Article  PubMed  Google Scholar 

  19. Wieczorek S, Gencik M, Rujescu D, et al. TNFA promoter polymorphisms and narcolepsy. Tissue Antigens. 2003;61(6):437–42.

    Article  CAS  PubMed  Google Scholar 

  20. Kato T, Honda M, Kuwata S, et al. Novel polymorphism in the promoter region of the tumor necrosis factor alpha gene: no association with narcolepsy. Am J Med Genet. 1999;88(4):301–4.

    Article  CAS  PubMed  Google Scholar 

  21. Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998;92(4):573–85.

    Article  CAS  PubMed  Google Scholar 

  22. Kanbayashi T, Inoue Y, Chiba S, et al. SF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia. J Sleep Res. 2002;11(1):91–3.

    Article  PubMed  Google Scholar 

  23. Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron. 2000;27(3):469–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet. 2000;355(9197):39–40.

    Article  CAS  PubMed  Google Scholar 

  25. Khatami R, Maret S, Werth E, et al. Monozygotic twins concordant for narcolepsy-cataplexy without any detectable abnormality in the hypocretin (orexin) pathway. Lancet. 2004;363(9416):1199–200.

    Article  CAS  PubMed  Google Scholar 

  26. Thannickal TC, Nienhuis R, Siegel JM. Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy. Sleep. 2009;32(8):993–8.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Scammell TE. The frustrating and mostly fruitless search for an autoimmune cause of narcolepsy. Sleep. 2006;29(5):601–2.

    Article  PubMed  Google Scholar 

  28. Tanaka S, Honda Y, Inoue Y, Honda M. Detection of autoantibodies against hypocretin, hcrtrl, and hcrtr2 in narcolepsy: anti-Hcrt system antibody in narcolepsy. Sleep. 2006;29(5):633–8.

    Article  PubMed  Google Scholar 

  29. Morgenthaler TI, Kapur VK, Brown T, et al. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep. 2007;30(12):1705–11.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Lernmark Å. Environmental factors in the etiology of type 1 diabetes, celiac disease, and Narcolepsy. Pediatr Diabetes. 2016;17:65–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Krystal A, Attarian H. Sleep medications and women: a review of issues to consider for optimizing the care of women with sleep disorders. Curr Sleep Med Rep. 2016;2(4):218–22.

    Article  Google Scholar 

  32. U.S. Xyrem Multicenter Study Group. Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy. Sleep Med. 2004;5(2):119–23.

    Article  Google Scholar 

  33. Calik MW. Update on the treatment of Narcolepsy: clinical efficacy of Pitolisant. Nat Sci Sleep. 2017;9:127–33.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Thorpy MJ, Shapiro C, Mayer G. A randomized study of Solriamfetol for excessive sleepiness in Narcolepsy. Ann Neurol. 2019;85(3):359–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. AlShareef SM, Smith RM, BaHammam AS. Kleine-Levin syndrome: clues to aetiology. Sleep Breath. 2018;22(3):613–23.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Katz JD, Ropper AH. Familial Kleine-Levin syndrome: two siblings with unusually long hypersomnic spells. Arch Neurol. 2002;59(12):1959–61.

    Article  PubMed  Google Scholar 

  37. Janicki S, Franco K, Zarko R. A case report of Kleine-Levin syndrome in an adolescent girl. Psychosomatics. 2001;42(4):350–2.

    Article  CAS  PubMed  Google Scholar 

  38. Dauvilliers Y, Mayer G, Lecendreux M, et al. Kleine-Levin syndrome: an autoimmune hypothesis based on clinical and genetic analyses. Neurology. 2002;59(11):1739–45.

    Article  CAS  PubMed  Google Scholar 

  39. BaHammam AS, GadElRab MO, Owais SM, Alswat K, Hamam KD. Clinical characteristics and HLA typing of a family with Kleine-Levin syndrome. Sleep Med. 2008;9(5):575–8.

    Article  PubMed  Google Scholar 

  40. Billiard M, Guilleminault C, Dement WC. A menstruation-linked periodic hypersomnia. Kleine-Levin syndrome or new clinical entity? Neurology. 1975;25(5):436–43.

    Article  CAS  PubMed  Google Scholar 

  41. Papy JJ, Conte-Devolx B, Sormani J, Porto R, Guillaume V. The periodic hypersomnia and megaphagia syndrome in a young female, correlated with menstrual cycle (author’s transl). Rev Electroencephalogr Neurophysiol Clin. 1982;12(1):54–61.

    Article  CAS  PubMed  Google Scholar 

  42. Sachs C, Persson HE, Hagenfeldt K. Menstruation-related periodic hypersomnia: a case study with successful treatment. Neurology. 1982;32(12):1376–9.

    Article  CAS  PubMed  Google Scholar 

  43. Bamford CR. Menstrual-associated sleep disorder: an unusual hypersomniac variant associated with both menstruation and amenorrhea with a possible link to prolactin and metoclopramide. Sleep. 1993;16(5):484–6.

    Article  CAS  PubMed  Google Scholar 

  44. Manber R, Bootzin RR. Sleep and the menstrual cycle. Health Psychol. 1997;16(3):209–14.

    Google Scholar 

  45. Arnulf I, Rico TJ, Mignot E. Diagnosis, disease course, and Management of Patients with Kleine-Levin syndrome. Lancet Neurol. 2012;11(10):918–28.

    Article  PubMed  Google Scholar 

  46. Huang YS, Lakkis C, Guilleminault C. Kleine-Levin syndrome: current status. Med Clin North Am. 2010;94(3):557–62.

    Article  PubMed  Google Scholar 

  47. de Oliveira MM, Conti C, Prado GF. Pharmacological treatment for Kleine-Levin syndrome. Cochrane Database Syst Rev. 2016;5:CD006685.

    Google Scholar 

  48. Dauvilliers Y, Evangelista E, Lopez R, et al. Absence of γ-aminobutyric acid-a receptor potentiation in central hypersomnolence disorders. Ann Neurol. 2016;80(2):259–68.

    Article  CAS  PubMed  Google Scholar 

  49. Lavault S, Dauvilliers Y, Drouot X, et al. Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy. Sleep Med. 2011;12(6):550–6.

    Article  PubMed  Google Scholar 

  50. Mayer G, Benes H, Young P, Bitterlich M, Rodenbeck A. Modafinil in the treatment of idiopathic hypersomnia without long sleep time – a randomized, double-blind, placebo-controlled study. J Sleep Res. 2015;24(1):74–81.

    Article  PubMed  Google Scholar 

  51. Trotti LM. Idiopathic hypersomnia. Sleep Med Clin. 2017;12(3):331–44.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Trotti LM, Saini P, Freeman AA, et al. Patients improvement in daytime sleepiness with clarithromycin in with GABA-related hypersomnia: clinical experience. J Psychopharmacol. 2014;28(7):697–702.

    Article  CAS  PubMed  Google Scholar 

  53. Trotti LM, Saini P, Koola C, LaBarbera V, Bliwise DL, Rye DB. Flumazenil for the treatment of refractory Hypersomnolence: clinical experience with 153 patients. J Clin Sleep Med. 2016;12(10):1389–94.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Voelker R. Women and depression. JAMA. 2001;285(11):1432.

    Google Scholar 

  55. Vgontzas AN, Bixler EO, Kales A, Criley C, Vela-Bueno A. Differences in nocturnal and daytime sleep between primary and psychiatric hypersomnia: diagnostic and treatment implications. Psychosom Med. 2000;62(2):220–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Reid, R.U., Attarian, H. (2020). Central Hypersomnias in Adult Women of Childbearing Age. In: Attarian, H., Viola-Saltzman, M. (eds) Sleep Disorders in Women. Current Clinical Neurology. Humana, Cham. https://doi.org/10.1007/978-3-030-40842-8_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-40842-8_15

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-030-40841-1

  • Online ISBN: 978-3-030-40842-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics